Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.

The global TB Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Vaccines.

Report Scope

The TB Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global TB Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the TB Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of TB Vaccines Market Report

Report Metric	Details
Report Name	TB Vaccines Market
CAGR	5%
Segment by Type	Immunotherapeutic Vaccines Booster Vaccines Others
Segment by Application	Hospitals Private Clinics Research Institutes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of TB Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the TB Vaccines Market report?

Ans: The main players in the TB Vaccines Market are Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut

What are the Application segmentation covered in the TB Vaccines Market report?

Ans: The Applications covered in the TB Vaccines Market report are Hospitals, Private Clinics, Research Institutes

What are the Type segmentation covered in the TB Vaccines Market report?

Ans: The Types covered in the TB Vaccines Market report are Immunotherapeutic Vaccines, Booster Vaccines, Others

1 TB Vaccines Market Overview

1.1 Product Overview and Scope of TB Vaccines

1.2 TB Vaccines Segment by Type

1.2.1 Global TB Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 Immunotherapeutic Vaccines

1.2.3 Booster Vaccines

1.2.4 Others

1.3 TB Vaccines Segment by Application

1.3.1 Global TB Vaccines Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Private Clinics

1.3.4 Research Institutes

1.4 Global TB Vaccines Market Size Estimates and Forecasts

1.4.1 Global TB Vaccines Revenue 2019-2030

1.4.2 Global TB Vaccines Sales 2019-2030

1.4.3 Global TB Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 TB Vaccines Market Competition by Manufacturers

2.1 Global TB Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global TB Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global TB Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global TB Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of TB Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of TB Vaccines, Product Type & Application

2.7 TB Vaccines Market Competitive Situation and Trends

2.7.1 TB Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest TB Vaccines Players Market Share by Revenue

2.7.3 Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 TB Vaccines Retrospective Market Scenario by Region

3.1 Global TB Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global TB Vaccines Global TB Vaccines Sales by Region: 2019-2030

3.2.1 Global TB Vaccines Sales by Region: 2019-2024

3.2.2 Global TB Vaccines Sales by Region: 2025-2030

3.3 Global TB Vaccines Global TB Vaccines Revenue by Region: 2019-2030

3.3.1 Global TB Vaccines Revenue by Region: 2019-2024

3.3.2 Global TB Vaccines Revenue by Region: 2025-2030

3.4 North America TB Vaccines Market Facts & Figures by Country

3.4.1 North America TB Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America TB Vaccines Sales by Country (2019-2030)

3.4.3 North America TB Vaccines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe TB Vaccines Market Facts & Figures by Country

3.5.1 Europe TB Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe TB Vaccines Sales by Country (2019-2030)

3.5.3 Europe TB Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific TB Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific TB Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific TB Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific TB Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America TB Vaccines Market Facts & Figures by Country

3.7.1 Latin America TB Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America TB Vaccines Sales by Country (2019-2030)

3.7.3 Latin America TB Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa TB Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa TB Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa TB Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa TB Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global TB Vaccines Sales by Type (2019-2030)

4.1.1 Global TB Vaccines Sales by Type (2019-2024)

4.1.2 Global TB Vaccines Sales by Type (2025-2030)

4.1.3 Global TB Vaccines Sales Market Share by Type (2019-2030)

4.2 Global TB Vaccines Revenue by Type (2019-2030)

4.2.1 Global TB Vaccines Revenue by Type (2019-2024)

4.2.2 Global TB Vaccines Revenue by Type (2025-2030)

4.2.3 Global TB Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global TB Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global TB Vaccines Sales by Application (2019-2030)

5.1.1 Global TB Vaccines Sales by Application (2019-2024)

5.1.2 Global TB Vaccines Sales by Application (2025-2030)

5.1.3 Global TB Vaccines Sales Market Share by Application (2019-2030)

5.2 Global TB Vaccines Revenue by Application (2019-2030)

5.2.1 Global TB Vaccines Revenue by Application (2019-2024)

5.2.2 Global TB Vaccines Revenue by Application (2025-2030)

5.2.3 Global TB Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global TB Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck & Co.,Inc

6.1.1 Merck & Co.,Inc Corporation Information

6.1.2 Merck & Co.,Inc Description and Business Overview

6.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck & Co.,Inc TB Vaccines Product Portfolio

6.1.5 Merck & Co.,Inc Recent Developments/Updates

6.2 Sanofi Pasteur

6.2.1 Sanofi Pasteur Corporation Information

6.2.2 Sanofi Pasteur Description and Business Overview

6.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sanofi Pasteur TB Vaccines Product Portfolio

6.2.5 Sanofi Pasteur Recent Developments/Updates

6.3 Japan BCG Laboratory

6.3.1 Japan BCG Laboratory Corporation Information

6.3.2 Japan BCG Laboratory Description and Business Overview

6.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Japan BCG Laboratory TB Vaccines Product Portfolio

6.3.5 Japan BCG Laboratory Recent Developments/Updates

6.4 China National Biotec Group

6.4.1 China National Biotec Group Corporation Information

6.4.2 China National Biotec Group Description and Business Overview

6.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 China National Biotec Group TB Vaccines Product Portfolio

6.4.5 China National Biotec Group Recent Developments/Updates

6.5 Serum Institute

6.5.1 Serum Institute Corporation Information

6.5.2 Serum Institute Description and Business Overview

6.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Serum Institute TB Vaccines Product Portfolio

6.5.5 Serum Institute Recent Developments/Updates

6.6 India Pvt. Ltd

6.6.1 India Pvt. Ltd Corporation Information

6.6.2 India Pvt. Ltd Description and Business Overview

6.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 India Pvt. Ltd TB Vaccines Product Portfolio

6.6.5 India Pvt. Ltd Recent Developments/Updates

6.7 InterVax Ltd

6.6.1 InterVax Ltd Corporation Information

6.6.2 InterVax Ltd Description and Business Overview

6.6.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 InterVax Ltd TB Vaccines Product Portfolio

6.7.5 InterVax Ltd Recent Developments/Updates

6.8 GreenSignal

6.8.1 GreenSignal Corporation Information

6.8.2 GreenSignal Description and Business Overview

6.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 GreenSignal TB Vaccines Product Portfolio

6.8.5 GreenSignal Recent Developments/Updates

6.9 Bio Pharma Limited

6.9.1 Bio Pharma Limited Corporation Information

6.9.2 Bio Pharma Limited Description and Business Overview

6.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Bio Pharma Limited TB Vaccines Product Portfolio

6.9.5 Bio Pharma Limited Recent Developments/Updates

6.10 Statens Serum Institut

6.10.1 Statens Serum Institut Corporation Information

6.10.2 Statens Serum Institut Description and Business Overview

6.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Statens Serum Institut TB Vaccines Product Portfolio

6.10.5 Statens Serum Institut Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 TB Vaccines Industry Chain Analysis

7.2 TB Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 TB Vaccines Production Mode & Process

7.4 TB Vaccines Sales and Marketing

7.4.1 TB Vaccines Sales Channels

7.4.2 TB Vaccines Distributors

7.5 TB Vaccines Customers

8 TB Vaccines Market Dynamics

8.1 TB Vaccines Industry Trends

8.2 TB Vaccines Market Drivers

8.3 TB Vaccines Market Challenges

8.4 TB Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck& Co. Inc

Sanofi Pasteur

Japan BCG Laboratory

China National Biotec Group

Statens Serum Institut

List of Tables

Table 1. Global TB Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global TB Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global TB Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global TB Vaccines Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global TB Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global TB Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global TB Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market TB Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of TB Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of TB Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of TB Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of TB Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global TB Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global TB Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global TB Vaccines Sales by Region (2019-2024) & (K Units)

Table 18. Global TB Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global TB Vaccines Sales by Region (2025-2030) & (K Units)

Table 20. Global TB Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global TB Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global TB Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global TB Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global TB Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 27. North America TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 28. North America TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 32. Europe TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 33. Europe TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific TB Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific TB Vaccines Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific TB Vaccines Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific TB Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific TB Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 42. Latin America TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 43. Latin America TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global TB Vaccines Sales (K Units) by Type (2019-2024)

Table 51. Global TB Vaccines Sales (K Units) by Type (2025-2030)

Table 52. Global TB Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global TB Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global TB Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global TB Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global TB Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global TB Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global TB Vaccines Price (USD/Unit) by Type (2019-2024)

Table 59. Global TB Vaccines Price (USD/Unit) by Type (2025-2030)

Table 60. Global TB Vaccines Sales (K Units) by Application (2019-2024)

Table 61. Global TB Vaccines Sales (K Units) by Application (2025-2030)

Table 62. Global TB Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global TB Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global TB Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global TB Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global TB Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global TB Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global TB Vaccines Price (USD/Unit) by Application (2019-2024)

Table 69. Global TB Vaccines Price (USD/Unit) by Application (2025-2030)

Table 70. Merck & Co.,Inc Corporation Information

Table 71. Merck & Co.,Inc Description and Business Overview

Table 72. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Merck & Co.,Inc TB Vaccines Product

Table 74. Merck & Co.,Inc Recent Developments/Updates

Table 75. Sanofi Pasteur Corporation Information

Table 76. Sanofi Pasteur Description and Business Overview

Table 77. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Sanofi Pasteur TB Vaccines Product

Table 79. Sanofi Pasteur Recent Developments/Updates

Table 80. Japan BCG Laboratory Corporation Information

Table 81. Japan BCG Laboratory Description and Business Overview

Table 82. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Japan BCG Laboratory TB Vaccines Product

Table 84. Japan BCG Laboratory Recent Developments/Updates

Table 85. China National Biotec Group Corporation Information

Table 86. China National Biotec Group Description and Business Overview

Table 87. China National Biotec Group TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. China National Biotec Group TB Vaccines Product

Table 89. China National Biotec Group Recent Developments/Updates

Table 90. Serum Institute Corporation Information

Table 91. Serum Institute Description and Business Overview

Table 92. Serum Institute TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Serum Institute TB Vaccines Product

Table 94. Serum Institute Recent Developments/Updates

Table 95. India Pvt. Ltd Corporation Information

Table 96. India Pvt. Ltd Description and Business Overview

Table 97. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. India Pvt. Ltd TB Vaccines Product

Table 99. India Pvt. Ltd Recent Developments/Updates

Table 100. InterVax Ltd Corporation Information

Table 101. InterVax Ltd Description and Business Overview

Table 102. InterVax Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. InterVax Ltd TB Vaccines Product

Table 104. InterVax Ltd Recent Developments/Updates

Table 105. GreenSignal Corporation Information

Table 106. GreenSignal Description and Business Overview

Table 107. GreenSignal TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. GreenSignal TB Vaccines Product

Table 109. GreenSignal Recent Developments/Updates

Table 110. Bio Pharma Limited Corporation Information

Table 111. Bio Pharma Limited Description and Business Overview

Table 112. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Bio Pharma Limited TB Vaccines Product

Table 114. Bio Pharma Limited Recent Developments/Updates

Table 115. Statens Serum Institut Corporation Information

Table 116. Statens Serum Institut Description and Business Overview

Table 117. Statens Serum Institut TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Statens Serum Institut TB Vaccines Product

Table 119. Statens Serum Institut Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. TB Vaccines Distributors List

Table 123. TB Vaccines Customers List

Table 124. TB Vaccines Market Trends

Table 125. TB Vaccines Market Drivers

Table 126. TB Vaccines Market Challenges

Table 127. TB Vaccines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of TB Vaccines

Figure 2. Global TB Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global TB Vaccines Market Share by Type in 2023 & 2030

Figure 4. Immunotherapeutic Vaccines Product Picture

Figure 5. Booster Vaccines Product Picture

Figure 6. Others Product Picture

Figure 7. Global TB Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global TB Vaccines Market Share by Application in 2023 & 2030

Figure 9. Hospitals

Figure 10. Private Clinics

Figure 11. Research Institutes

Figure 12. Global TB Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global TB Vaccines Market Size (2019-2030) & (US$ Million)

Figure 14. Global TB Vaccines Sales (2019-2030) & (K Units)

Figure 15. Global TB Vaccines Average Price (USD/Unit) & (2019-2030)

Figure 16. TB Vaccines Report Years Considered

Figure 17. TB Vaccines Sales Share by Manufacturers in 2023

Figure 18. Global TB Vaccines Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest TB Vaccines Players: Market Share by Revenue in 2023

Figure 20. TB Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global TB Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America TB Vaccines Sales Market Share by Country (2019-2030)

Figure 23. North America TB Vaccines Revenue Market Share by Country (2019-2030)

Figure 24. U.S. TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe TB Vaccines Sales Market Share by Country (2019-2030)

Figure 27. Europe TB Vaccines Revenue Market Share by Country (2019-2030)

Figure 28. Germany TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific TB Vaccines Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific TB Vaccines Revenue Market Share by Region (2019-2030)

Figure 35. China TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America TB Vaccines Sales Market Share by Country (2019-2030)

Figure 46. Latin America TB Vaccines Revenue Market Share by Country (2019-2030)

Figure 47. Mexico TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa TB Vaccines Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa TB Vaccines Revenue Market Share by Country (2019-2030)

Figure 52. Turkey TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE TB Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of TB Vaccines by Type (2019-2030)

Figure 56. Global Revenue Market Share of TB Vaccines by Type (2019-2030)

Figure 57. Global TB Vaccines Price (USD/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of TB Vaccines by Application (2019-2030)

Figure 59. Global Revenue Market Share of TB Vaccines by Application (2019-2030)

Figure 60. Global TB Vaccines Price (USD/Unit) by Application (2019-2030)

Figure 61. TB Vaccines Value Chain

Figure 62. TB Vaccines Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions